中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2014年
2期
105-106
,共2页
抗生素%宫炎康胶囊%慢性盆腔炎%临床效果
抗生素%宮炎康膠囊%慢性盆腔炎%臨床效果
항생소%궁염강효낭%만성분강염%림상효과
Antibiotics%Gongyankang capsule%Chronic pelvic inflammation%Clinical effect
目的：探讨抗生素联合宫炎康胶囊治疗慢性盆腔炎的临床效果。方法：选取本院2012年7月-2013年6月收治的64例慢性盆腔炎患者的临床资料进行研究分析，并按患者住院尾号分为治疗组（32例）和对照组（32例），比较两组患者治疗效果。结果：治疗组总有效率为96.88%，对照组为78.13%，两组比较差异有统计学意义（P<0.05）；两组患者治疗过程中均未发现不良反应；治疗组复发率（3.13%）低于对照组（9.38%）。结论：抗生素联合宫炎康胶囊治疗慢性盆腔炎疾病效果显著，且复发率较低，值得推广应用。
目的：探討抗生素聯閤宮炎康膠囊治療慢性盆腔炎的臨床效果。方法：選取本院2012年7月-2013年6月收治的64例慢性盆腔炎患者的臨床資料進行研究分析，併按患者住院尾號分為治療組（32例）和對照組（32例），比較兩組患者治療效果。結果：治療組總有效率為96.88%，對照組為78.13%，兩組比較差異有統計學意義（P<0.05）；兩組患者治療過程中均未髮現不良反應；治療組複髮率（3.13%）低于對照組（9.38%）。結論：抗生素聯閤宮炎康膠囊治療慢性盆腔炎疾病效果顯著，且複髮率較低，值得推廣應用。
목적：탐토항생소연합궁염강효낭치료만성분강염적림상효과。방법：선취본원2012년7월-2013년6월수치적64례만성분강염환자적림상자료진행연구분석，병안환자주원미호분위치료조（32례）화대조조（32례），비교량조환자치료효과。결과：치료조총유효솔위96.88%，대조조위78.13%，량조비교차이유통계학의의（P<0.05）；량조환자치료과정중균미발현불량반응；치료조복발솔（3.13%）저우대조조（9.38%）。결론：항생소연합궁염강효낭치료만성분강염질병효과현저，차복발솔교저，치득추엄응용。
Objective:To observe and analyze the clinical effect of antibiotics combined Gongyankang capsule in treatment of chronic pelvic inflammatory disease. Method:64 cases of chronic pelvic inflammatory disease patients from July 2012 to June 2013 were analyzed on the clinical data in the hospital in research according to the hospitalized patients with tail number divided into the treatment group(32 cases)and the control group(32 cases). The clinical effects between the two groups were compared after treatment. Result:The total effective rate of the control group was 78.13%while the treatment group was 96.88%after treatment,and the difference between the two groups was statistically significant(P<0.05). There were no adverse reactions of the two groups during treatment time. The recurrence rate of the treatment group(3.13%)was lower than the control group(9.38%). Conclusion:Antibiotics combined with Gongyankang capsule in treatment of chronic pelvic has significant effect,and the recurrence rate is low,is worth popularizing and application.
